Syntheses and studies of quinolone-cephalosporins as potential anti-tuberculosis agents

Bioorganic and Medicinal Chemistry Letters

Volumn 16, Issue 21, 2006, Pages 5534-5537

  Zhao, Gaiying ^a   Miller, Marvin J ^a   Franzblau, Scott ^b   Wan, Baojie ^b   Möllmann, Ute ^c  

^a UNIVERSITY OF NOTRE DAME   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c HANS KNÖLL INSTITUTE   (Germany)

Author keywords

Anti tuberculosis; Antibacterial agents; Quinolonyl lactams

Indexed keywords

AMINE; CEPHALOSPORIN; CEPHEM; QUINOLONE DERIVATIVE; TUBERCULOSTATIC AGENT;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFICACY; DRUG SYNTHESIS; GRAM NEGATIVE BACTERIUM; NONHUMAN;

ANTITUBERCULAR AGENTS; CEPHALOSPORINS; MYCOBACTERIUM TUBERCULOSIS; QUINOLONES;

BACTERIA (MICROORGANISMS); NEGIBACTERIA;

EID: 33748761972     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2006.08.045     Document Type: Article

References (17)

1. Bodiang C.K. Scott. Med. J. 45 (2000) 25
2. VanScoy R.E., and Wilkowske C.J. Mayo Clin. Proc. 74 (1999) 1038
3. Long R. Can. Med. Assoc. J. 163 (2000) 425
4. Gazdic A. Med. Arch. 52 (1998) 207
5. Pozniak A. Int. J. Tuberc. Lung Dis. 4 (2000) 993
6. Hershberger P.M., and Demuth Jr. T.P. In: Rosen B.P., and Mobashery S. (Eds). Resolving the Antibiotic Paradox: Progress in Understanding Drug Resistance and Development of New Antibiotics Vol. 13 (1998), Kluwer Academic/Plenum, New York 239
7. Stocksdale M.G., Ramurthy S., and Miller M. J. Org. Chem. 63 (1998) 1221
8. Sugiyama I., Komatsu Y., and Yamauchi H. J. Antibiot. 45 (1992) 103
9. Ma, X.; Davis, B. W.; O'hara, T. L.; Anthony, D. R.; Billings, D. M.; Maston, P. A.; White, R. E.; Krauss, H. J.; Berk, J. D.; Wood, N. A.; Loenigs, P. M.; Shah, S. K.; Shinabarger, D. L.; Twinem, T. L.; McOsker, C. C.; Kraft, W. G.; Rourke, F. J.; Demuth, Jr., T. P. In 34th Interscience Conference on Antimicrobial Agents Chemotherapy, Orlando, FL, October 4-7, 1994.
10. Gonzalez M., Rodriguez Z., Tolon B., Rodriguez J.C., Velez H., Valdes B., Lopez M.A., and Fini A. I1 Farmaco 58 (2003) 409
11. Demuth, T. P., Jr.; White, R. E.; Tietjen, R. A.; Ebetino, F. H.; Kraft, W. G.; Andersen, J. A.; McOsker, C. C.; Walling, M. A.; Davis, B. W.; Rourke, F. J. In 200th National Meeting of the American Chemical Society, Washington, DC, August 20-24; American Chemical Society: Washington, DC, 1990; MEDI-154.
12. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, approved standard. NCCLS Document M7-A5, 5th ed.; National Committee for Clinical Laboratory Standards: Villanova, PA, 2000.
13. Heinisch L., Wittmann S., Stoiber T., Berg A., Ankel-Fuchs D., and Möllmann U. J. Med. Chem. 45 (2002) 3032
14. Afonin S., Glaser R.W., Berditchevskaja M., Wadhwani P., Gührs K.-H., Möllmann U., Perner A., and Ulrich A.S. ChemBioChem 4 (2003) 1151
15. Collins L., and Franzblau S.G. Antimicrob. Agents Chemother. 41 (1997) 1004
16. De Voss J.J., Rutter K., Schroeder B.G., Su H., Zhu Y., and Barry III C.E. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 1252
17. Falzari K., Zhu Z., Pan D., Liu H., Hongmanee P., and Franzblau S.G. Antimicrob. Agents Chemother. 49 (2005) 1447